News

Pediatric Endocrine Society Publishes Guidelines for Evaluation and Management of Persistent Hypoglycemia


 

References

The Pediatric Endocrine Society has published guidelines to help physicians distinguish between transitional neonatal glucose regulation in normal newborns and hypoglycemia that persists or occurs for the first time beyond the first three days of life. Children with congenital hyperinsulinism are at risk for serious consequences, including seizures or permanent brain damage, without early identification and screening.

https://www.pedsendo.org/education_training/healthcare_providers/consensus_statements/assets/PES_recommendation_hypoglycemia.pdf

Recommended Reading

Cystic fibrosis–related diabetes requires different approach
MDedge Pediatrics
FDA panel supports approval of combination drug for cystic fibrosis
MDedge Pediatrics
Augmenting therapy boosts event-free survival in high-risk Wilms tumor
MDedge Pediatrics
Bill to speed FDA approvals includes rewards for drugs designed for kids
MDedge Pediatrics
Canada Adopts First-Ever Rare Disease Strategy
MDedge Pediatrics
NORD Issues Statement on Approval of 21st Century Cures Initiative and Introduction of OPEN Act
MDedge Pediatrics
Foundation for Prader-Willi Research and NORD Launch Global Registry
MDedge Pediatrics
NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)
MDedge Pediatrics
NIH Will Not Fund Gene-Editing Technologies in Human Embryos
MDedge Pediatrics
Drug Approved for LAM Illustrates How Patient Organizations Can Partner With Researchers
MDedge Pediatrics